Update on male hormonal contraception
Author(s) -
Gava Giulia,
Meriggiola Maria Cristina
Publication year - 2019
Publication title -
therapeutic advances in endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.889
H-Index - 30
eISSN - 2042-0196
pISSN - 2042-0188
DOI - 10.1177/2042018819834846
Subject(s) - medicine , family planning , hormonal contraception , developed country , condom , gynecology , male contraceptive , population , research methodology , family medicine , human immunodeficiency virus (hiv) , environmental health , syphilis
Despite increases in female contraceptive options, 40–45% of pregnancies across the world are still unplanned. While several effective female contraceptive methods have been developed, contraceptive choices for men are still limited to the male condom with its high failure rates and to vasectomies, which are invasive and not reliably reversible. Several studies have demonstrated a great interest among men and women for effective, reversible, and safe male contraceptive methods. Over the years, numerous studies have been performed to develop male hormonal and nonhormonal safe and effective contraceptives. A variety of new molecules are under development as oral or transdermal hormonal contraceptives for men demonstrating few side effects. In our overpopulated world, the development and commercialization of a male contraceptive method that will allow both men and women to take an active role in family planning is mandatory and further research on this topic is required.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom